Reshma Kewalramani
CEO & President · Vertex Pharmaceuticals Inc / MA (VRTX)
sold: $6,307,135
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 6, 2026 | Sale 10b5-1 plan notice filed | 11,866 | $531.53 | $6,307,135 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
